Showing results (201-210 of 283) with videos related to
Sort By:
Pageof 29
Archives of General Psychiatry|October 1, 1993
Strong inference, theory testing, and the neuroanatomy of schizophreniaW T Carpenter, R W Buchanan, B Kirkpatrick, et al.The American Journal of Psychiatry|August 1, 1978
Signs and symptoms as predictors of outcome: a report from the International Pilot Study of SchizophreniaW T Carpenter, J J Bartko, J S Strauss, et al.The American Journal of Psychiatry|June 10, 1998
Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndromeR W Buchanan, A Breier, B Kirkpatrick, et al.Biological Psychiatry|May 10, 2001
Long-term outcome of patients who receive ketamine during researchA C Lahti, D Warfel, T Michaelidis, et al.Archives of General Psychiatry|February 1, 1981
Des-tyrosine-gamma-endorphin administration in chronic schizophrenics. A preliminary reportC A Tamminga, P J Tighe, T N Chase, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 15, 2001
Effects of ketamine in normal and schizophrenic volunteersA C Lahti, M A Weiler, B A Tamara Michaelidis, et al.Synapse (New York, N.Y.)|July 1, 1995
Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatumR C Roberts, L A Gaither, X M Gao, et al.European Journal of Pharmacology|October 1, 1984
Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptorsM Knight, C A Tamminga, L Steardo, et al.Archives of General Psychiatry|April 1, 1986
Dopamine agonist treatment of schizophrenia with N-propylnorapomorphineC A Tamminga, M D Gotts, G K Thaker, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 28, 1998
[3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic studyR A Lahti, E V Cochrane, R C Roberts, et al.Pageof 29